Cargando…

Childhood Bacille Calmette‐Guérin vaccination seems to selectively protect adult males from COVID‐19 infection

Detalles Bibliográficos
Autores principales:	Jansson, Moritz K., Neuber, Kerstin, Rudolf, Henrik, Podbielski, Andreas, Virchow, J. Christian, Warnke, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011414/ https://www.ncbi.nlm.nih.gov/pubmed/34812526 http://dx.doi.org/10.1111/all.15186

Ejemplares similares

Bacille Calmette-Guérin: An ophthalmic perspective
por: Jain, Manish, et al.
Publicado: (2022)

Are Bacille Calmette-Guérin Skin Reactions the Most Important Correlates of Bacille Calmette-Guérin’s Specific and Nonspecific Effects?
por: Schaltz-Buchholzer, Frederik
Publicado: (2022)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011)

Determinants of Bacille Calmette-Guérin scarification in Danish children
por: Jensen, Trine Mølbæk, et al.
Publicado: (2021)

Gluteal abscess: An unusual complication of Bacille Calmette-Guérin
por: Buyukoglan, Hakan, et al.
Publicado: (2011)

Bacille-Calmette-Guerin non-responders: how to manage
por: von Rundstedt, Friedrich-Carl, et al.
Publicado: (2015)

Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
por: Fletcher, Helen A.
Publicado: (2016)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
por: Nieuwenhuizen, Natalie E., et al.
Publicado: (2018)

Revaccination with Bacille Calmette-Guérin: Some issues to consider
por: Datta, Manjula, et al.
Publicado: (2023)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
por: Huang, Di, et al.
Publicado: (2019)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
por: Chowdhury, Anadi Roy, et al.
Publicado: (2013)

Bacille Calmette–Guérin dosage; challenging dogmas and changing paradigms
por: Mansour, Ahmed M.
Publicado: (2015)

Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions
por: Venkataraman, Aishwarya, et al.
Publicado: (2015)

Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis
por: Huaman, Moises A., et al.
Publicado: (2020)

Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
por: Ehtesham, Nasreen Zafar, et al.
Publicado: (2020)

Disseminated Bacille Calmette-Guérin disease in immunocompetent adult patients
por: Nascimento, Luísa, et al.
Publicado: (2016)

Childhood Bacille Calmette-Guerin Vaccination and Its Association With Less Severe COVID-19 Pneumonia
por: Chen, Fan, et al.
Publicado: (2021)

Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018)

Bacille Calmette-Guérin Vaccination in Saudi Arabia: Benefits versus Risks
por: Al Jumaah, Suliman, et al.
Publicado: (2012)

3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis
por: Huaman, Moises, et al.
Publicado: (2019)

Tuberculous Spondylitis after Intrarenal Bacille Calmette-Guerin (BCG) Therapy
por: Kajihara, Yusaku, et al.
Publicado: (2019)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
por: Villanueva, Paola, et al.
Publicado: (2022)

Guillain Barré syndrome associated with bladder instillation of Bacille Calmette Guérin (BCG)
por: Webb, Karmel, et al.
Publicado: (2018)

Mycobacterial Arthritis at 19 Months After a Bacille Calmette–Guérin Vaccination
por: Lin, Chien-Yu, et al.
Publicado: (2017)

Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea
por: Choi, Youn Young, et al.
Publicado: (2018)

Nicotinamide Limits Replication of Mycobacterium tuberculosis and Bacille Calmette-Guérin Within Macrophages
por: Simmons, Jason D, et al.
Publicado: (2020)

Papulonecrotic tuberculid caused by Bacille Calmette-Guerin vaccination requiring no antitubercular agents
por: Araki, Kotaro, et al.
Publicado: (2020)

Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection
por: Chowdhury, Utpala Nanda, et al.
Publicado: (2021)

Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer
por: Yergin, Celeste G, et al.
Publicado: (2021)

Immunotherapy of COVID-19 with Bacille Calmette – Guerin: Where is the missing red herring?
por: Saxena, Hari M.
Publicado: (2021)

Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy
por: Villanueva, Paola, et al.
Publicado: (2022)

The Association Between Bacille Calmette-Guérin Vaccination and Nontuberculous Mycobacterial Pulmonary Disease
por: Kwak, Nakwon, et al.
Publicado: (2022)

Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
por: Villanueva, Paola, et al.
Publicado: (2023)

Bacille Calmette–Guerin Scar Reactivation: A Sign to Suggest Kawasaki Disease
por: Sharma, Avinash, et al.
Publicado: (2023)

Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
por: Villanueva, Paola, et al.
Publicado: (2023)

Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette–Guérin in mice
por: Painsipp, Evelin, et al.
Publicado: (2013)

Intravenous Bacille Calmette–Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis
por: Larson, Erica C., et al.
Publicado: (2023)

Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran
por: Sadeghi-Shanbestari, Mahnaz, et al.
Publicado: (2009)

The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette–Guérin immunization
por: Mawa, Patrice A., et al.
Publicado: (2015)

Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017
por: Nunes-Santos, Cristiane de Jesus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4fo6h5ceb4nh2fsqnsor929h75